Table 3b. The Panel’s Framework for Assessing the Risk of Progression to Severe COVID-19 Based on Patient Conditions and COVID-19 Vaccination Status
Last Updated: August 22, 2023
|Conditions||Risk Level by Vaccination Statusa|
|Unvaccinated||Primary Series||Up to Date|
|Strong or Consistent Association With Progression to Severe COVID-19|
|Moderate or Inconsistent Association With Progression to Severe COVID-19|
|Weak or Unknown Association With Progression to Severe COVID-19|
a Unvaccinated = individuals who are not eligible for COVID-19 vaccination or who are <2 weeks from the final dose of the primary series. Vaccinated with primary series = individuals who completed the primary series of 2 or 3 doses (the current CDC term is “fully vaccinated”) and are >2 weeks after the final dose of the primary series but have not received a booster, if they are eligible for a booster. Children aged <5 years are not currently eligible for booster doses. Vaccinated and up to date = individuals who received the recommended booster dose(s) if eligible or who have completed the primary series but are not yet eligible for a booster. See the current COVID-19 vaccination schedule from the CDC for more information.
b The degree of risk conferred by obesity in younger children is less clear than it is in older adolescents.
c This includes patients with a tracheostomy and those who require NIV.
d The data for this group are particularly limited.
Key: BMI = body mass index; CDC = Centers for Disease Control and Prevention; NIV = noninvasive ventilation; the Panel = the COVID-19 Treatment Guidelines Panel